TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6152435

Group type: EXPERIMENTAL
Intervention: Human insulin (0.075 U/kg body weight)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Porcine insulin (0.075 U/kg body weight)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bovine insulin (0.075 U/kg body weight)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Somatostatin (100 micrograms/h)
Number of subjects: 6
Study: 30997499

Group type: EXPERIMENTAL
Intervention: Sucrose (1.25-1.75 L of beverage sweetened with sucrose daily for 12 weeks)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Saccharin (1.25-1.75 L of beverage sweetened with saccharin daily for 12 weeks)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sucralose (1.25-1.75 L of beverage sweetened with sucralose daily for 12 weeks)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Aspartame (1.25-1.75 L of beverage sweetened with aspartame daily for 12 weeks)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Rebaudioside A (1.25-1.75 L of beverage sweetened with rebA daily for 12 weeks)
Number of subjects: 154
Study: 28691202

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 82
Study: 30627512

Group type: EXPERIMENTAL
Intervention: Chronic venous ulcers (CULEs) in diabetic patients
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Chronic venous ulcers (CULEs)
Number of subjects: 85
Study: 24872261

Group type: EXPERIMENTAL
Intervention: Unreamed interlocking intramedullary nail
Number of subjects: 40

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 40
Study: 22424018

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) of the occluded infarct-related artery
Number of subjects: 484

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 484
Study: 20649060

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate with potassium salt (GS‐K) 1500 mg daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Glucosamine sulfate with sodium salt (GS‐Na) 1500 mg daily
Number of subjects: 90
Study: 18379501

Group type: EXPERIMENTAL
Intervention: Semax (1% solution)
Number of subjects: 27
Study: 16076940

Group type: EXPERIMENTAL
Intervention: Serum 1,25-dihydroxyvitamin D
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: PTH
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 25-OHD
Number of subjects: 93
Study: 12384844

Group type: EXPERIMENTAL
Intervention: Nevirapine (Nvp), stavudine (d4T), and indinavir (Idv; 1000 mg 3 times daily)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Lamivudine (3TC), stavudine (d4T), and indinavir (Idv; 800 mg 3 times daily)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Nevirapine (Nvp)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Lamivudine (3TC)
Number of subjects: 145
Study: 10562790

Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 40
Study: 8909210

Group type: EXPERIMENTAL
Intervention: Single running 10-0 nylon suture with postoperative suture tension adjustment (Group 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combined running and interrupted 10-0 nylon sutures with selective postoperative removal of interrupted sutures (Group 2)
Number of subjects: 32
Study: 1809720

Group type: EXPERIMENTAL
Intervention: Low level laser treatment (GAAS pulsed laser)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham laser treatment
Number of subjects: 40
Study: 6853932

Group type: EXPERIMENTAL
Intervention: Cortisol (8 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isoproterenol (240 micrograms)
Number of subjects: 19
Study: 28902034

Group type: EXPERIMENTAL
Intervention: 1,060-nm diode laser treatment
Number of subjects: 49
Study: 29129191

Group type: EXPERIMENTAL
Intervention: Cocaine abstinence behavioral intervention
Number of subjects: 239
Study: 25839918

Group type: EXPERIMENTAL
Intervention: Microvascular decompression (MVD)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Balloon compression (BC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 78
Study: 24004891

Group type: EXPERIMENTAL
Intervention: Orange-fleshed sweet potatoes (12 mg β-carotene/d)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Tangerines (5.3 mg β-cryptoxanthin/d)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: White-fleshed sweet potatoes with a vitamin A supplement (0.5 mg/d)
Number of subjects: 135

Group type: COMPARATOR
Intervention: White-fleshed sweet potatoes 2 times/d, 6 d/wk for 3 wk
Number of subjects: 135
Study: 20189491

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM administered concomitantly with Tdap and HPV vaccines
Number of subjects: 1620

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM administered sequentially with Tdap and HPV vaccines
Number of subjects: 1620
Study: 18946011

Group type: EXPERIMENTAL
Intervention: Interdental brushing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flossing
Number of subjects: 0
Study: 16981000

Group type: EXPERIMENTAL
Intervention: 2 h infusion of CsA 3 mg/kg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Continuous infusion of CsA 3 mg/kg/day
Number of subjects: 21
Study: 15239026

Group type: EXPERIMENTAL
Intervention: Repaglinide (1 mg pre-meal 3 x/day) + Metformin (2550 mg/day)
Number of subjects: 11
Study: 10908008

Group type: EXPERIMENTAL
Intervention: Research conducted in community treatment organizations
Number of subjects: 0
Study: 9368727

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy (CHART)
Number of subjects: 526

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 526
Study: 8446968

Group type: EXPERIMENTAL
Intervention: Aspirin (two doses)
Number of subjects: 2993
Study: 3543037

Group type: EXPERIMENTAL
Intervention: 3 injections of cefamandole (at induction of anesthesia and after 4 and 10 hours)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: 8 injections of cefamandole (at induction of anesthesia, after 4 hours, then every 6 hours up to 40 hours)
Number of subjects: 507
Study: 2900021

Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 905

Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 905
Study: 29664800

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery plus extended counseling (n = 80)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Enhanced recovery after surgery with standard counseling (n = 84)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Both groups (extended counseling and standard counseling)
Number of subjects: 164
Study: 26419459

Group type: EXPERIMENTAL
Intervention: Purine analogues (PAs)
Number of subjects: 156

Group type: COMPARATOR
Intervention: No purine analogues (PAs)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 156
Study: 25515692

Group type: EXPERIMENTAL
Intervention: 180 mg of PSE in the morning (AM(PSE))
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 180 mg of PSE in the afternoon (PM(PSE))
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo in the morning (AM(PLAC))
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo in the afternoon (PM(PLAC))
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 180 mg of PSE
Number of subjects: 9
Study: 23065316

Group type: EXPERIMENTAL
Intervention: Interactive Workshop (IW)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Conventional Education (CE)
Number of subjects: 203
Study: 20635521

Group type: EXPERIMENTAL
Intervention: Music training (n = 18)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Speech training (n = 18)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No training (Control, n = 14)
Number of subjects: 50
Study: 18373989

Group type: EXPERIMENTAL
Intervention: Upper-body exercise program using an arm crank ergometer 3 times a week for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Upper-body exercise program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups (training and control)
Number of subjects: 20
Study: 16340195

Group type: COMPARATOR
Intervention: Topical acyclovir (ACV) ointment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir (VACV)
Number of subjects: 28
Study: 15134308

Group type: EXPERIMENTAL
Intervention: 1 mg GH/m2/day
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 2 mg GH/m2/day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 79
Study: 11561869

Group type: EXPERIMENTAL
Intervention: Enzyme treatment (trypsin, chymotrypsin, and papain)
Number of subjects: 120
Study: 9051139

Group type: COMPARATOR
Intervention: Granisetron (40 micrograms/kg) only
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms/kg) plus steroids (500 mg of methylprednisolone or 8 mg of dexamethasone)
Number of subjects: 62
Study: 8117868

Group type: EXPERIMENTAL
Intervention: Binifibrate
Number of subjects: 54

Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 54
Study: 3511184

Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tamoxifen (10 mg twice daily)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy (crossover treatment)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tamoxifen (crossover treatment)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy (visceral dominant subset)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tamoxifen (visceral dominant subset)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy (crossover in visceral dominant nonresponders)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Time to progression (initial treatment)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Survival rates
Number of subjects: 53
Study: 31992444

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Negative margin resection
Number of subjects: 305

Group type: COMPARATOR
Intervention: Positive margin resection
Number of subjects: 305
Study: 29882738

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) with a wavelength of 660 nm, 30 mW power, continuous mode emission, 6 J/cm2 dosimetry, applied every 48 hours for 4 weeks.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control Group (no specific intervention details provided).
Number of subjects: 18
Study: 27606275

Group type: EXPERIMENTAL
Intervention: Corrective fusion surgery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (N=44)
Number of subjects: 47
Study: 24798786

Group type: EXPERIMENTAL
Intervention: NT-proBNP measurement
Number of subjects: 177
Study: 22669054

Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery (Group 2)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional rotary instruments (Group 1)
Number of subjects: 140
Study: 24576068

Group type: EXPERIMENTAL
Intervention: 3 doses of sulphadoxine-pyrimethamine (SP3)
Number of subjects: 1274

Group type: COMPARATOR
Intervention: 2 doses of sulphadoxine-pyrimethamine (SP2)
Number of subjects: 1274
Study: 18603751

Group type: EXPERIMENTAL
Intervention: Transvenous, intracardial cardioversion (TIC) with ALERT pulmonary artery catheter
Number of subjects: 18

Group type: COMPARATOR
Intervention: Amiodarone treatment with standard pulmonary artery catheter
Number of subjects: 18
Study: 15756217

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 15
Study: 12464202

Group type: EXPERIMENTAL
Intervention: Sternocleidomastoid flap
Number of subjects: 36
Study: 10693099

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (chlorothiazide)
Number of subjects: 0
Study: 9352867

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: ISMN
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 8450258

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Pyrimethamine/sulfadoxine
Number of subjects: 226
Study: 3093214

Group type: EXPERIMENTAL
Intervention: Withdrawal of carbamazepine (CBZ)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Withdrawal of phenytoin (PHT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Progabide (PGB)
Number of subjects: 30
Study: 30950698

Group type: EXPERIMENTAL
Intervention: Stretch‐and‐flow voice therapy (SnF)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Resonant voice therapy (RVT)
Number of subjects: 21
Study: 26321418

Group type: EXPERIMENTAL
Intervention: Test meal with variety (three different varieties of vegetables, meat or fish, and starch components)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control meal without variety
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Test meal with variety
Number of subjects: 19
Study: 23800482

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study: 21558568

Group type: EXPERIMENTAL
Intervention: Guided relaxation and exercise imagery (GREI) audio CD for 6 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo control group with relaxation tracks and music for 6 weeks
Number of subjects: 93
Study: 19453572

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (planning when, where and how to floss)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 194
Study: 16919161

Group type: EXPERIMENTAL
Intervention: SFC (50/100 mcg)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: FBC (4.5/160 mcg)
Number of subjects: 108
Study: 15327603

Group type: EXPERIMENTAL
Intervention: Spontaneous delivery (n=235)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Manual removal (n=237)
Number of subjects: 472
Study: 11350283

Group type: EXPERIMENTAL
Intervention: Low molecular-weight heparin
Number of subjects: 449

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Hyperdense middle cerebral artery sign (HMCAS)
Number of subjects: 449
Study: 9121987

Group type: EXPERIMENTAL
Intervention: PCD Jewel 7219C (14 patients)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: PCD Jewel 7219D (37 patients)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Overall patient group
Number of subjects: 51
Study: 8202180

Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 183

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 183
Study: 3428842

Group type: EXPERIMENTAL
Intervention: Methyclothiazide 2 mg alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methyclothiazide 2 mg with triamterene 25 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methyclothiazide 2 mg with larger doses of triamterene
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 8
Study: 31670388

Group type: EXPERIMENTAL
Intervention: DNA methylations in UBE2L3 and BLK genes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mRNA expression of UBE2L3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mRNA expression of BLK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: plasma cathepsin B level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UBE2L3 gene expression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BLK single nucleotide polymorphisms
Number of subjects: 0
Study: 30133775

Group type: EXPERIMENTAL
Intervention: Online mental health role‐play simulation (45-90 minutes)
Number of subjects: 18896
Study: 28797238

Group type: EXPERIMENTAL
Intervention: Brace wearing for 6 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: No brace for 6 weeks
Number of subjects: 126
Study: 25814467

Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α treatment
Number of subjects: 77
Study: 23376601

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for treating child emotional and behavioral symptoms following trauma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal PTSD symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced interventions targeting dyads with child PTSD symptoms and maternal depression or PTSD symptoms
Number of subjects: 0
Study: 22087846

Group type: EXPERIMENTAL
Intervention: Heavy-intensity exercise (HIE) followed by moderate-intensity exercise (MIE) test 1, test 2, and test 3.
Number of subjects: 19
Study: 18635446

Group type: EXPERIMENTAL
Intervention: LPS (4 ng/kg body wt)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 18
Study: 16826105

Group type: EXPERIMENTAL
Intervention: Mobile-bearing tibial component
Number of subjects: 52

Group type: COMPARATOR
Intervention: Fixed-bearing tibial component
Number of subjects: 52
Study: 12821205

Group type: EXPERIMENTAL
Intervention: Transfer at 30 mg methadone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Transfer when 'uncomfortable' dosing protocol
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Transfer from doses less than 30 mg methadone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Buprenorphine induction (first dose 4 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Follow-up at 1 month
Number of subjects: 51
Study: 12845731

Group type: EXPERIMENTAL
Intervention: Aprotinin (1,000,000 KIU by vein injection and 2,000,000 KIU as a bolus in prime)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study: 9308590

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) in patients less than 50 years old
Number of subjects: 26

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA) in patients greater than 55 years old (Control)
Number of subjects: 26
Study: 7640544

Group type: EXPERIMENTAL
Intervention: Active transdermal nicotine patches
Number of subjects: 629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 629
Study: 2565314

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate, 25 mg daily for 25 days with 5 days' rest each month
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ascorbic acid, 500 mg daily
Number of subjects: 100
Study: 338090

Group type: EXPERIMENTAL
Intervention: Hydrotalcite
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31276502

Group type: EXPERIMENTAL
Intervention: Telemedicine patient support program (MSP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Technical support only (Control)
Number of subjects: 93
Study: 28495620

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500mg/day) during pregnancy
Number of subjects: 450000

Group type: COMPARATOR
Intervention: Placebo during pregnancy
Number of subjects: 450000
Study: 26197451

Group type: EXPERIMENTAL
Intervention: 200 mg of AZD9056 administered orally as a tablet once daily for 28 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 34
Study: 25607793

Group type: EXPERIMENTAL
Intervention: Skin barrier emulsion cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional moisturizer
Number of subjects: 0
Study: 22343536

Group type: EXPERIMENTAL
Intervention: Achieved SBP between 131 and 141 mmHg
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Achieved SBP 130 mmHg or less
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Achieved SBP at least 142 mmHg
Number of subjects: 9193
Study: 19207770

Group type: EXPERIMENTAL
Intervention: Double linear endocardial ablation of left lateral isthmus (LLI) along the vein of Marshall (VOM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No LLI block (control group)
Number of subjects: 54
Study: 17577006

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 11
Study: 16294458

Group type: EXPERIMENTAL
Intervention: 1 mg 17beta‐E2/0.25 mg TMG
Number of subjects: 1218

Group type: COMPARATOR
Intervention: 1 mg E2V/1 mg NET
Number of subjects: 1218
Study: 11934964

Group type: EXPERIMENTAL
Intervention: Glucosamine sulphate 1500 mg daily for 6 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9774808

Group type: EXPERIMENTAL
Intervention: Heme iron‐fortified cookies for 6‐8 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no fortification)
Number of subjects: 108
Study: 8697383

Group type: EXPERIMENTAL
Intervention: Curative resection only
Number of subjects: 572
Study: 1758415

Group type: EXPERIMENTAL
Intervention: Non-absorbable membrane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Absorbable membrane
Number of subjects: 0
Study: 7151087

Group type: EXPERIMENTAL
Intervention: Tiapamil (1.1 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tiapamil (1.6 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verapamil (0.07 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verapamil (0.14 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tiapamil and Verapamil
Number of subjects: 60
Study: 30850995

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 7637

Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 7637
Study: 28376899

Group type: EXPERIMENTAL
Intervention: Oats consumption (70 g of oats twice a day for 4 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 80
Study: 25406260

Group type: EXPERIMENTAL
Intervention: High-fat/high-carbohydrate (HFHC) meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: American Heart Association (AHA) meal
Number of subjects: 10
Study: 23813322

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention consisting of 6 workshops on diabetes prevention, nutrition, physical activity, diabetes complications, stress and family support, and access to health care
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 48